Harrow Health, Inc. 11.875% Senior Notes due 2027 (NASDAQ:HROWM) Short Interest Update

Harrow Health, Inc. 11.875% Senior Notes due 2027 (NASDAQ:HROWM) was the recipient of a large growth in short interest in the month of September. As of September 15th, there was short interest totalling 1,300 shares, a growth of 225.0% from the August 31st total of 400 shares. Based on an average trading volume of 4,700 shares, the short-interest ratio is currently 0.3 days.

Harrow Health, Inc. 11.875% Senior Notes due 2027 Price Performance

Shares of NASDAQ:HROWM traded up $0.01 during midday trading on Friday, reaching $26.81. The company’s stock had a trading volume of 893 shares, compared to its average volume of 4,201. The business has a 50 day moving average price of $26.30 and a 200 day moving average price of $26.35. Harrow Health, Inc. 11.875% Senior Notes due 2027 has a 1 year low of $22.71 and a 1 year high of $27.72.

Harrow Health, Inc. 11.875% Senior Notes due 2027 Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Wednesday, July 31st. Shareholders of record on Monday, July 15th were issued a $0.7422 dividend. This represents a $2.97 annualized dividend and a yield of 11.07%. The ex-dividend date of this dividend was Monday, July 15th.

Harrow Health, Inc. 11.875% Senior Notes due 2027 Company Profile

harrow health, inc., together with its subsidiaries, develops, produces, and sells medications for unmet needs primarily in the united states. the company primarily provides ophthalmology based formulations to physicians and patients; and sterile and non-sterile compounded medications. it also develops and commercializes therapeutics for treating ocular surface diseases; and non-intravenous sedation and anesthesia therapeutics for human medical procedures in hospital, outpatient, and in-office settings.